WC Chen
Biographic Data
| ID | 9274740 |
|---|---|
| NAME | WC Chen |
| GIVEN NAMES | WC |
| FAMILY NAME | Chen |
| SIGNATURE | CHEN W |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2013 |
| H-INDEX | 0 |
Wu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis- a prospective randomized controlled trial
Wu-Ling-San (WLS) formula has been proved to prevent calcium oxalate nephrolithiasis both in vitro and in vivo. This is the first prospective, randomized and placebo-controlled clinical trial of WLS in calcium oxalate nephrolithiasis prevention. All patients who enrolled were asked to drink enough fluid to urinate at least 2 L daily during the study period. A 24-hour urine collection was performed to establish the baseline levels of multiple urin…
Acarbose
Acarbose, which is clinically widely used to treat Type 2 Diabetes, is thought to act at the small intestine by competitively inhibiting enzymes that delay the release of glucose from complex carbohydrates, thereby specifically reducing post prandial glucose excursion. The major side-effect of treatment with acarbose, flatulence, occurs when undigested carbohydrates are fermented by colonic bacteria, resulting in considerable amount of hydrogen. …
No prominent works on this page.
Acarbose
Acarbose, which is clinically widely used to treat Type 2 Diabetes, is thought to act at the small intestine by competitively inhibiting enzymes that delay the release of glucose from complex carbohydrates, thereby specifically reducing post prandial glucose excursion. The major side-effect of treatment with acarbose, flatulence, occurs when undigested carbohydrates are fermented by colonic bacteria, resulting in considerable amount of hydrogen. …
Wu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis- a prospective randomized controlled trial
Wu-Ling-San (WLS) formula has been proved to prevent calcium oxalate nephrolithiasis both in vitro and in vivo. This is the first prospective, randomized and placebo-controlled clinical trial of WLS in calcium oxalate nephrolithiasis prevention. All patients who enrolled were asked to drink enough fluid to urinate at least 2 L daily during the study period. A 24-hour urine collection was performed to establish the baseline levels of multiple urin…
Internal Medicine (2 works) · Medicine (2 works) · Acarbose (1 work) · Biochemical effects in animals (1 work) · Biochemistry (1 work) · Calcium oxalate (1 work) · Chemistry (1 work) · Clinical trial (1 work) · Diabetes mellitus (1 work) · Diet and metabolism studies (1 work)